Long-Acting Injectable vs Oral Antipsychotics for Maintenance Treatment of Schizophrenia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Acting Injectable Versus Oral Antipsychotics for the Maintenance Treatment of Schizophrenia: A Systematic Review and Comparative Meta-Analysis of Randomised, Cohort, and Pre-Post Studies
Lancet Psychiatry 2021 May 01;8(5)387-404, T Kishimoto, K Hagi, S Kurokawa, JM Kane, CU CorrellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.